Diseases /

Ampulla of Vater Adenocarcinoma

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: An invasive carcinoma with glandular differentiation arising from the ampulla of Vater. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. [1]

Ampulla of vater adenocarcinomas most frequently harbor alterations in KRAS, TP53, CDKN2A, SMAD4, and APC [2].

Most Commonly Altered Genes in Ampulla of Vater Adenocarcinoma

KRAS Mutation, KRAS Exon 2 Mutation, KRAS Codon 12 Missense, TP53 Mutation, and TP53 c.217-c.1178 Missense are the most common alterations in ampulla of vater adenocarcinoma [2].

Top Alterations in Ampulla of Vater Adenocarcinoma

Clinical Trials

View Clinical Trials for Ampulla of Vater Adenocarcinoma

Disease Details

Synonyms
Adenocarcinoma of Ampulla of Vater, Ampullary Adenocarcinoma, Invasive Adenocarcinoma of the Ampullary Region
Parent(s)
Ampulla of Vater Carcinoma
Children
Ampulla of Vater Mucinous Adenocarcinoma, Ampulla of Vater Pancreatobiliary Type Adenocarcinoma, Ampulla of Vater Intestinal Type Adenocarcinoma, Ampulla of Vater Signet Ring Cell Carcinoma, and Ampulla of Vater Clear Cell Adenocarcinoma

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.